Moderna Shares Rise Ahead of Upcoming Conference and Pipeline Updates
Moderna (MRNA) shares rose 7.49% to $49.06 as investors anticipated updates from the company at an upcoming conference and its annual shareholders' meeting. The stock is set to participate in Goldman Sachs’ Global Healthcare Conference on June 9, where it will present pipeline progress.